Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Understanding the pros and cons of different treatments may help men and their health care teams make more informed treatment decisions.
American Cancer Society stresses the need for early detection, screening and prevention strategies, especially for at-risk communities.
Plus: NCCN calls for solutions to the shortage that’s affecting common treatments for breast, blood, lung and prostate cancers.
Andy Taylor, Tim Commerford, Jamie Raskin and Martina Navratilova make cancer headlines.
The patient-driven Metastatic Prostate Cancer Research Project releases its first report.
Defining one of cancer’s most common and intimidating terms
Study confirms that Black men are at higher risk for prostate cancer disease progression and death.
Black men had “a significantly higher incidence” of both localized and metastatic prostate cancer. But researchers reported good news too.
Young Black men who received PSA testing more often were 40% less likely to be diagnosed with advanced prostate cancer.
The FDA-approved test determines both whether prostate cancer has metastasized and where those tumor cells can be found.
The benefit of reduced mortality must be balanced against the harms of overdiagnosis.
These men lived for a median of 30 months compared to 26 months for white men.
Living with cancer can have detrimental effects on bone health, leading to pain, impaired mobility and increased risk of fractures.
Studies show African-American men may respond better to treatment and survive longer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.